Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury

Hormones and Behavior

Volumn 61, Issue 4, 2012, Pages 642-651

  Hua, Fang ^a   Reiss, Jenny I ^a   Tang, Huiling ^a   Wang, Jun ^a   Fowler, Xavier ^a   Sayeed, Iqbal ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Combination treatments; Functional repair; Progesterone; Traumatic brain injury; Vitamin D3 hormone

Indexed keywords

CALCITRIOL; GLIAL FIBRILLARY ACIDIC PROTEIN; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CONTUSION; CELL ACTIVATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FRONTAL CORTEX; LOCOMOTION; LOW DRUG DOSE; MALE; MEDIAL FRONTAL CORTEX; MEMORY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; REFERENCE MEMORY; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY;

ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN INJURIES; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEINS; FLUORESCENT DYES; FRONTAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MEMORY DISORDERS; MOTOR ACTIVITY; NECROSIS; NEURONS; NEUROPROTECTIVE AGENTS; PROGESTERONE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SENSATION DISORDERS; SURVIVAL; VITAMIN D; VITAMINS;

EID: 84862822527     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2012.02.017     Document Type: Article

References (55)

1. Atif F., Sayeed I., Ishrat T., Stein D.G. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol. Med. 2009, 15:328-336.
2. Baldi E., Efoudebe M., Lorenzini C.A., Bucherelli C. Spatial navigation in the Morris water maze: working and long lasting reference memories. Neurosci. Lett. 2005, 378:176-180.
3. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 2001, 21:98-108.
4. Buell J.S., Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline?. Mol. Aspects Med. 2008, 29:415-422.
5. Cai W., Zhu Y., Furuya K., Li Z., Sokabe M., Chen L. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 2008, 55:127-138.
6. Cekic M., Stein D.G. Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem?. Neurotherapeutics 2010, 7:81-90.
7. Cekic M., Sayeed I., Stein D.G. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front. Neuroendocrinol. 2009, 30:158-172.
8. Cekic M., Cutler S.M., VanLandingham J.W., Stein D.G. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol. Aging 2011, 32(5):864-874. Epub 2009 May 30.
9. Chang J.H., Cha H.R., Lee D.S., Seo K.Y., Kweon M.N. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 2010, 5:e12925.
10. Chatterjee M. Vitamin D and genomic stability. Mutat. Res. 2001, 475:69-87.
11. Chen Y., Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 2003, 23:137-149.
12. Ciriza I., Azcoitia I., Garcia-Segura L.M. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 2004, 16:58-63.
13. Ciriza I., Carrero P., Frye C.A., Garcia-Segura L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 2006, 66:916-928.
14. Cutler S.M., Vanlandingham J.W., Stein D.G. Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp. Neurol. 2006, 200:378-385.
15. Cutler S.M., Cekic M., Miller D.M., Wali B., VanLandingham J.W., Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 2007, 24:1475-1486.
16. De Keyser J., Mostert J.P., Koch M.W. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 2008, 267:3-16.
17. de Viragh P.A., Haglid K.G., Celio M.R. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:3887-3890.
18. Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402.
19. Devan B.D., McDonald R.J., White N.M. Effects of medial and lateral caudate-putamen lesions on place- and cue-guided behaviors in the water maze: relation to thigmotaxis. Behav. Brain Res. 1999, 100:5-14.
20. Ehara A., Ueda S. Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences. Acta Histochem. Cytochem. 2009, 42:171-179.
21. Ferretti V., Sargolini F., Oliverio A., Mele A., Roullet P. Effects of intra-accumbens NMDA and AMPA receptor antagonists on short-term spatial learning in the Morris water maze task. Behav. Brain Res. 2007, 179:43-49.
22. Frielingsdorf H., Thal L.J., Pizzo D.P. The septohippocampal cholinergic system and spatial working memory in the Morris water maze. Behav. Brain Res. 2006, 168:37-46.
23. Gangisetty O., Reddy D.S. Neurosteroid withdrawal regulates GABA-A receptor alpha4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway. Neuroscience 2010, 170:865-880.
24. Garay L., Tungler V., Deniselle M.C., Lima A., Roig P., De Nicola A.F. Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience 2011, 192:588-597.
25. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 2002, 13:100-105.
26. Gibson C.L., Coomber B., Murphy S.P. Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 2011, 134:2125-2133.
27. Goss C.W., Hoffman S.W., Stein D.G. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol. Biochem. Behav. 2003, 76:231-242.
28. Grossman K.J., Goss C.W., Stein D.G. Effects of progesterone on the inflammatory response to brain injury in the rat. Brain Res. 2004, 1008:29-39.
29. Gunn B.G., Brown A.R., Lambert J.J., Belelli D. Neurosteroids and GABA(A) receptor interactions: a focus on stress. Front. Neurosci. 2011, 5:131. Epub 2011 Dec 5.
30. Guo Q., Sayeed I., Baronne L.M., Hoffman S.W., Guennoun R., Stein D.G. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol. 2006, 198:469-478.
31. Hazell A.S. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 2007, 50:941-953.
32. Hu Z., Li Y., Fang M., Wai M.S., Yew D.T. Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration. Curr. Med. Chem. 2009, 16:1418-1425.
33. Ishrat T., Sayeed I., Atif F., Stein D.G. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res. 2009, 1257:94-101.
34. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 2010, 226:183-190.
35. Jones G. Pharmacokinetics of vitamin D toxicity. Am. J. Clin. Nutr. 2008, 88:582S-586S.
36. Kajta M., Makarewicz D., Zieminska E., Jantas D., Domin H., Lason W., Kutner A., Lazarewicz J.W. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro. Neurochem. Int. 2009, 55:265-274.
37. Lin A.M., Chen K.B., Chao P.L. Antioxidative effect of vitamin D3 on zinc-induced oxidative stress in CNS. Ann. N. Y. Acad. Sci. 2005, 1053:319-329.
38. Losem-Heinrichs E., Gorg B., Redecker C., Schleicher A., Witte O.W., Zilles K., Bidmon H.J. 1alpha,25-dihydroxy-vitamin D3 in combination with 17beta-estradiol lowers the cortical expression of heat shock protein-27 following experimentally induced focal cortical ischemia in rats. Arch. Biochem. Biophys. 2005, 439:70-79.
39. Margulies S., Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J. Neurotrauma 2009, 26:925-939.
40. McCann J.C., Ames B.N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J. 2008, 22:982-1001.
41. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
42. Paulson P.E., Robinson T.E. Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav. Neurosci. 1994, 108:624-635.
43. Prior H., Schwegler H., Ducker G. Dissociation of spatial reference memory, spatial working memory, and hippocampal mossy fiber distribution in two rat strains differing in emotionality. Behav. Brain Res. 1997, 87(2):183-194.
44. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 2008, 57:386-397.
45. Stein D.G. Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?. Dialogues in Clinical Neuroscience 2011, 13:352-359.
46. Stein D.G., Cekic M.M. Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged. PMR 2011, 3(6 Suppl 1):S100-S110.
47. Stein D.G., Hurn P.D. Effects of sex steroids on damaged neural systems. Hormones, Brain and Behavior 2009, 2223-2258. Elsevier, Oxford. 2 ed. D.W. Pfaff, A.P. Arnold, A.M. Etgen, S.E. Fahrbach, R.T. Rubin (Eds.).
48. Stein D.G., Wright D.W. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin. Investig. Drugs 2010, 19:847-857.
49. Thacher T.D., Clarke B.L. Vitamin D insufficiency. Mayo Clin. Proc. 2011, 86:50-60.
50. Vieth R. The mechanisms of vitamin D toxicity. Bone Miner. 1990, 11:267-272.
51. Wali B., Sayeed I., Stein D.G. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor. Neurol. Neurosci. 2011, 29:61-71.
52. Wang J., Jiang C., Liu C., Li X., Chen N., Hao Y. Neuroprotective effects of progesterone following stroke in aged rats. Behav. Brain Res. 2010, 209:119-122.
53. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury. Ann. Emer. Med. 2007, 49:391-402.
54. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a 769 randomized controlled trial. Crit. Care 2008, 12:R61.
55. Zhang R., Naughton D.P. Vitamin D in health and disease: current perspectives. Nutr. J. 2010, 9:65.